REDDY HOLDING GMBH
ItalyAll drugs from this manufacturer
-
It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss related to long-term glucocorticoid use in patients at risk of fracture.
Dosage form: solution for injection in pre-filled syringe
Active substance Dosage denosumab - ATC: M05BX04
-
This medicine is used to treat several conditions in adults and children, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris.
Dosage form: solution for infusion, concentrate
Active substance Dosage rituximab - ATC: L01XC02
-
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or pressure on the bone marrow) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Dosage form: solution for injection
Active substance Dosage denosumab - ATC: M05BX04